Disc Medicine, Inc. (IRON)
NASDAQ · Healthcare
$74.38-2.32%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $2.93B
- P/E ratio
- —
- EPS
- —
- Volume
- 310,556
- 52-week high
- —
- 52-week low
- —
- Open
- $76.15
- Day high
- $77.48
- Day low
- $74.19
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | — | -$212.18M | -$6.01 |
| 2024 | — | -$109.36M | -$3.96 |
| 2023 | — | -$76.43M | -$3.42 |
| 2022 | — | -$46.83M | -$45.05 |
| 2021 | — | -$35.97M | -$40.95 |
About Disc Medicine, Inc.
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
- CEO
- John D. Quisel
- Employees
- 94
- Country
- US
- IPO date
- Aug 12, 2020
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Disc Medicine, Inc.'s stock price today?
- IRON is trading at $74.38 as of Jul 20, 2026.
- What is Disc Medicine, Inc.'s market cap?
- Disc Medicine, Inc. (IRON) has a market capitalization of $2.93B.
- Does Disc Medicine, Inc. pay a dividend?
- Disc Medicine, Inc. did not pay a dividend in its most recent reported fiscal year.
- What sector is Disc Medicine, Inc. in?
- Disc Medicine, Inc. operates in the Healthcare sector.